The Vaccine Adjuvant Chitosan Promotes Cellular Immunity via DNA Sensor cGAS-STING-Dependent Induction of Type I Interferons
about
DNA sensor cGAS-mediated immune recognitionMultifaceted Applications of Chitosan in Cancer Drug Delivery and Therapy.The shape and size of hydroxyapatite particles dictate inflammatory responses following implantation.Chitin and Its Effects on Inflammatory and Immune Responses.The Mechanism for Type I Interferon Induction by Mycobacterium tuberculosis is Bacterial Strain-Dependent.The Emerging Roles of STING in Bacterial Infections.Recent advances in chitosan-based nanoparticulate pulmonary drug delivery.New pharmaceutical approaches for the treatment of food allergies.Impact of Type I Interferon on the Safety and Immunogenicity of an Experimental Live-Attenuated Herpes Simplex Virus 1 Vaccine in Mice.The Common R71H-G230A-R293Q Human TMEM173 Is a Null Allele.Adjuvants for allergy immunotherapeutics.Cytosolic nucleic acid sensors and innate immune regulation.Mitochondrial DNA in innate immune responses and inflammatory pathology.Formulation of chitosan with the polyepitope HIV-1 protein candidate vaccine efficiently boosts cellular immune responses in mice.Improving the efficacy of a prophylactic vaccine formulation against lymphatic filariasis.Immunoprotective Effect of Chitosan Particles on Hymenolepis nana - Infected Mice.A STING-activating nanovaccine for cancer immunotherapy.Synthetic nanovaccines for immunotherapy.Repeated Treatments with Chitosan in Combination with Antibiotics Completely Eradicate Uropathogenic Escherichia coli From Infected Mouse Urinary Bladders.Th2 responses are primed by skin dendritic cells with distinct transcriptional profiles.Herpesvirus-Associated Lymphadenitis Distorts Fibroblastic Reticular Cell Microarchitecture and Attenuates CD8 T Cell Responses to Neurotropic Infection in Mice Lacking the STING-IFNα/β Defense Pathways.Anti-cancer efficacy of biotinylated chitosan nanoparticles in liver cancer.Nanomaterials in the Prevention, Diagnosis, and Treatment of Mycobacterium Tuberculosis Infections.Sublingual targeting of STING with 3'3'-cGAMP promotes systemic and mucosal immunity against anthrax toxins.Impact of heat shock protein 60KD in combination with outer membrane proteins on immune response against Brucella melitensis.Chitosan immunomodulatory properties: perspectives on the impact of structural properties and dosage.cGAS/STING Pathway in Cancer: Jekyll and Hyde Story of Cancer Immune Response.Identification and Characterization of Stimulator of Interferon Genes As a Robust Adjuvant Target for Early Life Immunization.Elevated sodium chloride drives type I interferon signaling in macrophages and increases antiviral resistance.Cytosolic sensing of immuno-stimulatory DNA, the enemy within.Perspectives in allergen immunotherapy: 2017 and beyond.Immunogenicity of the nanovaccine containing intimin recombinant protein in the BALB/c mice.Chitosan-DNA nanoparticles enhanced the immunogenicity of multivalent DNA vaccination on mice against Trueperella pyogenes infection.Stability and bioactivity of chitosan as a transfection agent in primary human cell cultures: A case for chitosan-only controls.Nanoparticle-Fusion Protein Complexes Protect against Mycobacterium tuberculosis Infection.Hippo interferes with antiviral defences.Virus-Like Particle, Liposome, and Polymeric Particle-Based Vaccines against HIV-1.Mucosal Immunity and Protective Efficacy of Intranasal Inactivated Influenza Vaccine Is Improved by Chitosan Nanoparticle Delivery in Pigs.A review of biomaterials in bone defect healing, remaining shortcomings and future opportunities for bone tissue engineering: The unsolved challenge.Chitosan Microsphere Used as an Effective System to Deliver a Linked Antigenic Peptides Vaccine Protect Mice Against Acute and Chronic Toxoplasmosis.
P2860
Q28073115-8C5B1B2E-1638-4B03-9B4C-DB7EB0CDF4F3Q33612179-AD78FA2D-A3BE-4AFF-BF24-3B3A47A7C69FQ33774310-9EFB93DE-4128-4487-8952-97FBA9F75F44Q34552477-6C4CB793-9CE5-4191-8098-B8969816C115Q36097401-F7410769-B752-4FD1-B8A3-4829045D68AAQ37833954-AC329BB5-71FF-436C-ADE4-20F36A375B0FQ38903481-C2F16FB0-1429-4117-B187-E4722C4FD466Q38978845-39A984C5-B06E-4FB8-B548-B6040790E6F6Q38998931-77F0F937-2C09-415F-9D13-31628A50E8E9Q39121627-839C1675-E839-48A5-93A3-B93CDB1573BAQ39151158-5FB25988-5C31-48BA-A717-98E9BB43C044Q39195781-5C1905EC-1F1A-4026-A56D-22FB6F74B1CEQ39231387-B51DDDD5-7175-44C0-B9D0-B9E635BE8157Q40040813-90C9A123-5459-4BE1-B538-FBE1858DDBA1Q40084746-AAFD7CA7-F343-457F-A8CB-C13BC39B6B6FQ40209260-C1A61D82-441A-4957-9F94-A4F7E57B2469Q40230470-2BA7BC34-B63B-4636-9848-E885BC7EBD0BQ40280801-062F3C4E-BB2B-431A-BB28-80DE05D6B201Q40359535-0E21CF3D-66E0-48BF-8BEC-743C634B57DBQ40540246-DC624D7D-EFA6-47FA-B01C-8B7A79CE24E3Q40580558-E2953C9E-D369-4BE7-AD33-D8E72707E7A2Q41709085-25550179-03CE-4280-BF7A-A51DEA6E32D1Q41931571-53E7C6B2-E7A5-40EC-B8C0-00A3AEBEE379Q43170567-336A0B9C-8C81-4D23-A45F-5667D216924BQ46258488-93C442AA-6191-419B-BBF0-272C96B7A594Q47100559-35927EFA-25F0-4C5C-809B-B9F2D73A5C05Q47132136-8AD04DD3-0DF1-456C-9EDF-26F4A93CB5B4Q47169865-5CD11E23-72CA-44CF-AAC0-AE12D57AF653Q47371006-86CE0D17-994B-45BC-B878-709BC984D431Q47564798-8E8BCA40-CDBF-4D76-84C2-A9206D14F399Q47700986-27ABAE2B-1A3A-4B87-A876-9E423FA38AF1Q48109105-B21D8BA7-CDC3-4603-B507-DA19ADF2382AQ49278291-FDBCA0E3-63C7-4371-A412-1EE0667ECD16Q50153578-F7F3E206-3258-457F-94C4-7A313302F54FQ50531820-C011593B-F182-498E-AB29-BE68B87B838BQ50938512-3A517409-88F1-4E2D-B35A-53A2DC9982C3Q52655238-F31C6AEE-27CA-4A15-AF02-29815AB451EFQ54209314-905BD1C9-C1CA-486A-852D-D83E29B84FAAQ55162982-EB5EDE4E-A7D1-4CDC-99AA-233CBF6D8B68Q55224227-F2630B63-9996-4AF3-90E0-2B35086A4586
P2860
The Vaccine Adjuvant Chitosan Promotes Cellular Immunity via DNA Sensor cGAS-STING-Dependent Induction of Type I Interferons
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
The Vaccine Adjuvant Chitosan ...... nduction of Type I Interferons
@en
type
label
The Vaccine Adjuvant Chitosan ...... nduction of Type I Interferons
@en
prefLabel
The Vaccine Adjuvant Chitosan ...... nduction of Type I Interferons
@en
P2093
P2860
P50
P1433
P1476
The Vaccine Adjuvant Chitosan ...... nduction of Type I Interferons
@en
P2093
Andres Mori
Eimear Lambe
Elizabeth C Carroll
Else Marie Agger
Ewa Oleszycka
Hannah B T Moran
Katherine A Fitzgerald
Samira Mansouri
P2860
P304
P356
10.1016/J.IMMUNI.2016.02.004
P407
P50
P577
2016-02-29T00:00:00Z